A federal appeals court on Tuesday revived a lawsuit by a whistleblower who accused McKesson of providing drug pricing tools to doctors for free, to induce them to buy drugs from the company.

McKesson Corp. said its longtime Chairman and Chief Executive John H. Hammergren will retire next year, capping a 17-year reign in which he helped build one of the country’s largest ...

McKesson Corp. has reached a tentative $141 million settlement with shareholders who sued claiming the drug distributor hid that it profited from a price-fixing conspiracy among generic drugmakers.

McKesson has entered into a definitive agreement to acquire CoverMyMeds, a developer of electronic prior authorization technology, for $1.1 billion or $0.9 billion net of cash incremental cash ...

McKesson released its Q4 FY 2025 result on May 8th after the market close, posting 19% revenue growth and 63.8% adj. EPS growth. As detailed in the table below, ...